(Q38112399)

English

HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression

scientific article published on 05 June 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 August 2017

HIF expression and the role of hypoxic microenvironments within primary tumours as protective sites driving cancer stem cell renewal and metastatic progression (English)

1 reference

Europe PubMed Central

29 August 2017

0 references

neoplastic stem cells

1 reference

based on heuristic

inferred from title

Rafael Moreno-Sanchez

3

object named as

Rafael Moreno-Sánchez

1 reference

Europe PubMed Central

29 August 2017

author name string

Beatrice Philip

1

1 reference

Europe PubMed Central

29 August 2017

Koichi Ito

2

1 reference

Europe PubMed Central

29 August 2017

Stephen J Ralph

4

1 reference

Europe PubMed Central

29 August 2017

language of work or name

0 references

publication date

5 June 2013

1 reference

Europe PubMed Central

29 August 2017

1 reference

Europe PubMed Central

29 August 2017

34

1 reference

Europe PubMed Central

29 August 2017

8

1 reference

Europe PubMed Central

29 August 2017

1699-1707

1 reference

Europe PubMed Central

29 August 2017

Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Rapid xenograft tumor progression in beta-arrestin1 transgenic mice due to enhanced tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Identification of arctigenin as an antitumor agent having the ability to eliminate the tolerance of cancer cells to nutrient starvation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia-inducible factor 1alpha is regulated by the mammalian target of rapamycin (mTOR) via an mTOR signaling motif

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia-inducible factor 1alpha and erythropoietin upregulation with deferoxamine salvage after neonatal stroke.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

HIF-1alpha modulates energy metabolism in cancer cells by inducing over-expression of specific glycolytic isoforms.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Severe hypoxia induces chemo-resistance in clinical cervical tumors through MVP over-expression.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Radiosensitization of normoxic and hypoxic h1339 lung tumor cells by heat shock protein 90 inhibition is independent of hypoxia inducible factor-1α

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Basal HIF-1α expression levels are not predictive for radiosensitivity of human cancer cell lines

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Prognostic significance of hypoxia-inducible factor-1alpha, TWIST1 and Snail expression in resectable non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1alpha in normoxia

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Molecular characterization of two mammalian bHLH-PAS domain proteins selectively expressed in the central nervous system

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

HIF-1 and HIF-2 transcription factors--similar but not identical

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

HIF-2alpha promotes hypoxic cell proliferation by enhancing c-myc transcriptional activity

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

On the mechanism of iron sensing by IRP2: new players, new paradigms

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

The oxygen sensor factor-inhibiting hypoxia-inducible factor-1 controls expression of distinct genes through the bifunctional transcriptional character of hypoxia-inducible factor-1alpha

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Direct regulation of TWIST by HIF-1alpha promotes metastasis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Mutation analysis of HIF prolyl hydroxylases (PHD/EGLN) in individuals with features of phaeochromocytoma and renal cell carcinoma susceptibility

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Characterization and comparative analysis of the EGLN gene family

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Cellular oxygen sensing need in CNS function: physiological and pathological implications

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Expression, purification and characterization of human PHD1 in Escherichia coli

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Differential function of the prolyl hydroxylases PHD1, PHD2, and PHD3 in the regulation of hypoxia-inducible factor

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Oxygen sensing by HIF hydroxylases

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Prolyl hydroxylases 2 and 3 act in gliomas as protective negative feedback regulators of hypoxia-inducible factors

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Regulation of the prolyl hydroxylase domain protein 2 (phd2/egln-1) gene: identification of a functional hypoxia-responsive element

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Placental but not heart defects are associated with elevated hypoxia-inducible factor alpha levels in mice lacking prolyl hydroxylase domain protein 2

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Cytoplasmic location of factor-inhibiting hypoxia-inducible factor is associated with an enhanced hypoxic response and a shorter survival in invasive breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

The asparaginyl hydroxylase factor inhibiting HIF-1alpha is an essential regulator of metabolism

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

LINDAU'S DISEASE. REVIEW OF THE LITERATURE AND STUDY OF A LARGE KINDRED.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia inactivates the VHL tumor suppressor through PIASy-mediated SUMO modification

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

The pVHL-associated SCF ubiquitin ligase complex: molecular genetic analysis of elongin B and C, Rbx1 and HIF-1alpha in renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Proline hydroxylation and gene expression

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Molecular basis of the VHL hereditary cancer syndrome

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Enhancement of angiogenesis through stabilization of hypoxia-inducible factor-1 by silencing prolyl hydroxylase domain-2 gene

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Tumour suppression by the human von Hippel-Lindau gene product

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

SUMO-specific protease 1 is essential for stabilization of HIF1alpha during hypoxia

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Cell-permeating alpha-ketoglutarate derivatives alleviate pseudohypoxia in succinate dehydrogenase-deficient cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Mutations of the metabolic genes IDH1, IDH2, and SDHAF2 are not major determinants of the pseudohypoxic phenotype of sporadic pheochromocytomas and paragangliomas

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Role of VHL gene mutation in human cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Neuronal apoptosis by prolyl hydroxylation: implication in nervous system tumours and the Warburg conundrum

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia-inducible factor 1 activation by aerobic glycolysis implicates the Warburg effect in carcinogenesis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Research resource: Transcriptional profiling reveals different pseudohypoxic signatures in SDHB and VHL-related pheochromocytomas

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Accumulation of Krebs cycle intermediates and over-expression of HIF1alpha in tumours which result from germline FH and SDH mutations

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Endogenous 2-oxoglutarate levels impact potencies of competitive HIF prolyl hydroxylase inhibitors

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

The pentose phosphate pathway of glucose metabolism. Enzyme profiles and transient and steady-state content of intermediates of alternative pathways of glucose metabolism in Krebs ascites cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Inhibition of hypoxia-inducible factor (HIF) hydroxylases by citric acid cycle intermediates: possible links between cell metabolism and stabilization of HIF.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Reversible inactivation of HIF-1 prolyl hydroxylases allows cell metabolism to control basal HIF-1.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Mechanism of the Prolyl Hydroxylase Reaction. 1. Role of Co-substrates

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Mechanism of the Prolyl Hydroxylase Reaction. 2. Kinetic Analysis of the Reaction Sequence

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Dysregulation of hypoxia pathways in fumarate hydratase-deficient cells is independent of defective mitochondrial metabolism.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Fumarase: a mitochondrial metabolic enzyme and a cytosolic/nuclear component of the DNA damage response

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Glioma-derived mutations in IDH1 dominantly inhibit IDH1 catalytic activity and induce HIF-1alpha

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

The genetic basis of kidney cancer: a metabolic disease

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Mutation of von Hippel-Lindau tumour suppressor and human cardiopulmonary physiology

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Effects of HIF-1alpha and HIF2alpha on Growth and Metabolism of Clear-Cell Renal Cell Carcinoma 786-0 Xenografts

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Thiodigalactoside inhibits murine cancers by concurrently blocking effects of galectin-1 on immune dysregulation, angiogenesis and protection against oxidative stress.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Endothelial deletion of hypoxia-inducible factor-2alpha (HIF-2alpha) alters vascular function and tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

The hypoxia-associated factor switches cells from HIF-1α- to HIF-2α-dependent signaling promoting stem cell characteristics, aggressive tumor growth and invasion

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Oxidative phosphorylation is impaired by prolonged hypoxia in breast and possibly in cervix carcinoma

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Identification of a stem-like cell population by exposing metastatic breast cancer cell lines to repetitive cycles of hypoxia and reoxygenation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Overexpression of c-myc induces epithelial mesenchymal transition in mammary epithelial cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

MYC and metastasis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Tumor suppressors and cell metabolism: a recipe for cancer growth

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Reciprocal influence of the p53 and the hypoxic pathways

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

EMT: a new vision of hypoxia promoting cancer progression

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia, Snail and incomplete epithelial-mesenchymal transition in breast cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia Attenuates the Expression of E-Cadherin via Up-Regulation of SNAIL in Ovarian Carcinoma Cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Redox mechanisms switch on hypoxia-dependent epithelial-mesenchymal transition in cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Notch signaling mediates hypoxia-induced tumor cell migration and invasion

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Immune surveillance of tumors

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Macrophage expression of hypoxia-inducible factor-1 alpha suppresses T-cell function and promotes tumor progression

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia skews dendritic cells to a T helper type 2-stimulating phenotype and promotes tumour cell migration by dendritic cell-derived osteopontin

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and T(reg) cells.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

A2A adenosine receptor protects tumors from antitumor T cells.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Macrophage responses to hypoxia: implications for tumor progression and anti-cancer therapies

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia-driven immunosuppression: a new reason to use thermal therapy in the treatment of cancer?

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Galectin-1: a link between tumor hypoxia and tumor immune privilege

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

c-Myc transactivation of LDH-A: implications for tumor metabolism and growth

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Suppression of T-cell responses by tumor metabolites

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Metabolic profiling of hypoxic cells revealed a catabolic signature required for cell survival

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Tumor hypoxia has independent predictor impact only in patients with node-negative cervix cancer.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia-inducible factors, stem cells, and cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia inducible factors in cancer stem cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

The hypoxic microenvironment upgrades stem-like properties of ovarian cancer cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

HIF induces human embryonic stem cell markers in cancer cells.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

A restricted cell population propagates glioblastoma growth after chemotherapy

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Breast cancer stem cells: treatment resistance and therapeutic opportunities

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxic tumor microenvironment and cancer cell differentiation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Intermittent hypoxia regulates stem-like characteristics and differentiation of neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Sox2 and Oct-3/4: a versatile pair of master regulators that orchestrate the self-renewal and pluripotency of embryonic stem cells

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Pluripotency factors Lin28 and Oct4 identify a sub-population of stem cell-like cells in ovarian cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Passing the baton: the HIF switch

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Human cancers converge at the HIF-2alpha oncogenic axis.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia and metastasis

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Lowering of tumor interstitial fluid pressure reduces tumor cell proliferation in a xenograft tumor model

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia and metabolism. Hypoxia, DNA repair and genetic instability.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hypoxia-inducible factor 1 as a possible target for cancer chemoprevention

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

New drugs target hypoxia response in tumors

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Targeting hypoxic tumour cells to overcome metastasis.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104.

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Targeting hypoxia in cancer therapy

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Bacterial therapies: completing the cancer treatment toolbox

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Hallmarks of Cancer: The Next Generation

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGT209

21 January 2018

Identifiers

10.1093/CARCIN/BGT209

1 reference

Europe PubMed Central

29 August 2017

1 reference

Europe PubMed Central

29 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38112399&oldid=1742249456"